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Background: Catheter-associated urinary tract infections (CAUTIs) are among the most
common hospital-acquired infections, leading to increased morbidity and mortality. A
major reason for this is that urinary catheters are not yet capable of preventing CAUTIs.
Aim: To develop an anti-infective urinary catheter.
Methods: An efficient silver-polytetrafluoroethylene (Ag-PTFE) nanocomposite coating
was deposited on whole silicone catheters, and two in-vitro bladder models were designed
to test antibacterial (against Escherichia coli) and anti-encrustation (against Proteus
mirabilis) performances. Each model was challenged with two different concentrations of
bacterial suspension.
Findings: Compared with uncoated catheters, coated catheters significantly inhibited
bacterial migration and biofilm formation on the external catheter surfaces. The time to
develop bacteriuria was an average of 1.8 days vs 4 days and 6 days vs 41 days when the
urethral meatus was infected with 106 and 102 cells/mL, respectively. For anti-
encrustation tests, the coated catheter significantly resisted encrustation, although it
did not strongly inhibit the increases in bacterial density and urinary pH. The time to
blockage, which was found to be independent of the initial bacterial concentration in the
bladder, was extended from 36.21.1 h (uncoated) to 89.53.54 h (coated) following
bacterial contamination with 103 cells/mL in the bladder. Moreover, the coated catheter
exhibited excellent biocompatibility with L929 fibroblast cells.
Conclusion: Ag-PTFE coated Foley catheters should undergo further clinical trials to
determine their ability to prevent CAUTIs during catheterization.
ª 2019 The Author(s). Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Science and Engineering, University of Dundee, Dundee DD1 4HN, UK. Tel.: þ44 (0) 1382 385651.
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Urinary catheters that drain urine for patients during and
after surgery or in critical illness are common indwelling
medical devices in hospitals, with 23.6% of patients in 183
US hospitals having a catheter [1,2]. However, the resulting
risk of catheter-associated urinary tract infections (CAUTIs)
is challenging. CAUTIs account for approximately 40% of
hospital-acquired infections in the USA each year, and can
lead to longer hospital stay, bacteriuria, urosepsis and
death [3,4].
The risk of developing bacteriuria increases by 3e7% for
each additional day that the indwelling catheter remains in
situ [5], and bacteriuria is universal in patients after 30 days of
indwelling catheterization [1,6]. Another critical issue of
catheterization is the encrustation of urinary catheters, caused
by Proteus mirabilis. P. mirabilis increases the pH of urine, and
thus crystals of calcium and magnesium phosphates from urine
block the eye-hole and lumen of the catheter, leading to
painful distension of the bladder or even pyelonephritis and
septicaemia [7].
Over recent decades, many attempts have been made to
cover the catheter surface with coatings that inhibit bacterial
colonization (e.g. antibiotics, polymers and silver alloy) in
order to prevent CAUTIs [8e10]. However, to date, no coated
catheters that are effective for chronic catheterization are
commercially available, and bacteriuria remains inevitable
[11]. The silver-coated urinary catheter, as one of the few anti-
infective catheters widely available on the market, can reduce
infections when the indwelling silver-coated catheter is in
place for one week or less, but has an insignificant effect for
longer durations [12,13]. This may be because the biofilm
surrounding silver-coated surfaces could be sticky mucoid,
which will inactivate the antibacterial properties of silver
coatings [14]. Thus, the authors believe that it would be
desirable to develop a silver-coated catheter with non-stick
properties. As a biomedical material, PTFE has excellent non-
stick properties with an exceptionally low coefficient of fric-
tion [15,16], and the Ag-PTFE composite would be a promising
antibacterial coating for urinary catheters. The authors’ pre-
vious research has reported Ag-PTFE composite coatings on
stainless steel substrates which exhibited outstanding resist-
ance to bacterial adhesion [17,18]. Thus, in this study, in order
to develop an anti-infective indwelling catheter, economical,
efficient and biocompatible Ag-PTFE nanocomposite coatings
were deposited on whole silicone catheters, with the aim of
preventing colonization of Escherichia coli which is the most
common organism leading to CAUTIs [1,19], and inhibiting the
encrustation caused by P. mirabilis.
Two in-vitro bladder models were designed to evaluate
the ability of whole coated catheters to: (1) impede bacte-
rial migration along external surfaces of the catheter; and
(2) inhibit encrustation. Bare silicone catheters were used as
the control. For the first model, the coated and uncoated
catheters were challenged with two concentrations of E. coli
suspension: 106 and 102 cells/mL. For the second model, the
coated and uncoated catheters were incubated with two
concentrations of P. mirabilis suspension: 106 and 103 cells/
mL. Encrustation indicates that urine has been con-
taminated, so the starting level of bacteriuria was selected
as the low concentration.Materials and methods
Materials
The all-silicone two-way Foley catheters (16 Fr., diameter
5.3 mm) were purchased from Mediplus Ltd (High Wycombe,
UK). Silver nitrate and saccharin sodium were purchased from
Fisher Scientific (Loughborough, UK), and all other reagents
were purchased from Sigma-Aldrich (Gillingham, UK).
Ag-PTFE nanocomposite coatings on silicone catheters
The detailed coating procedure and the related character-
ization of the coating surface have been described elsewhere
[17,18]. Briefly, an aqueous solution containing 0.05 M Tween
20, 0.03 M silver nitrate and 0.04 M sodium saccharine was
stirred for 1 min before placed in a water bath at 70C. 5 mL/L
PTFE emulsion (60.0 wt% with PTFE particle size in the range
0.05e0.5 mm) and 0.2 g/L of FC-4 cationic surfactant were
added and mixed thoroughly by sonication for 10 min at room
temperature. The entire Foley catheter was immersed in
coating solution, and the ratio of catheter surface area/volume
of coating solution (RCV) was determined as 72 mm2/mL (see
online supplementary material). After being coated for 4 h at
70C, the coated catheter was taken out; rinsed successively
with 0.1 M HNO3, ultra-pure water and absolute ethanol; and
dried at room temperature.
Bacterial strains, media and culture
E. coli (F1693) was obtained from the Institute of Infection
and Immunity, Nottingham University, UK and P. mirabilis
(ATCC 51286) was bought from the American Type Culture
Collection (Manassas, VA, USA). A single colony of a strain was
inoculated into a test tube containing 5 mL of tryptic soy broth
(TSB) and grown overnight at 37C, with agitation at 200 rpm.
Fifty microlitres of this overnight culture was transferred into
10 mL of TSB and incubated with shaking until the mid-
exponential phase was reached (OD600 0.6) to obtain the bac-
terial suspension in TSB, corresponding to a bacterial density of
w2108 cells/mL for E. coli or w1108 cells/mL for
P. mirabilis.
In-vitro antibacterial performance of whole coated
catheters in bladder model
An in-vitro bladder model was designed as shown in
Figure 1a to mimic bacterial infection in most cases of CAUTI,
which result from bacteria colonizing the cathetereurethral
meatus interface and migrating along the external surface of
the catheter into the bladder [8,20]. The model consisted of a
glass vessel maintained at 37C by a water heating jacket
(‘bladder’), an acrylic tube with a length of 13 cm and an inner
diameter of 6 mm (‘urethra’, based on the average lengths of
male and female urethra [21,22]) and two peristaltic pumps.
The branch at the bottom of the acrylic tube could allow the
source of infection to be injected, thus representing the ure-
thral meatus. After sterilization of the model, the sterile whole
catheter with Ag-PTFE nanocomposite coatings or the whole
bare silicone catheter was inserted aseptically via the ‘ure-



























Figure 1. Schematic diagram illustrating in-vitro bladder models to study: (a) bacterial migration along the external surface of catheters;
and (b) encrustation of the eye-hole and lumen of catheters.
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glycerine solution. In order to make the urine medium drip
down from the ‘bladder’ along the ‘urethra’, there was a 0.5-
cm gap between the bottom of the balloon and the top of the
‘urethra’. The artificial urine (pH 6.0) was prepared according
to the supporting information in the literature [23], but the TSB
component was altered to 8.0 g/L. The sterile artificial urine
was pumped into the ‘bladder’ at a rate of 0.5 mL/min. The
source of infection was prepared using E. coli suspension
diluted with 5% dextrose. Two concentrations of w 2106 and
w2102 cells/mL were applied to challenge the inserted
catheter. The source of infection (prepared and renewed each
day) was pumped into the ‘urethral meatus’ at a rate of 0.2
mL/min, allowing bacteria to attach and colonize on the
catheters.
One millilitre of urine medium in the ‘bladder’ was col-
lected daily through the sampling port to measure bacterial
density using the plate count method. When bacteriuria (103
cells/mL) occurred, the time taken to develop bacteriuria was
recorded, and the catheter was removed from the model. The
catheter section infected in the ‘urethra’ was cut into 2-cm-
long segments, and then the biofilm formation on these seg-
ments was determined using crystal violet staining [24]. Briefly,
each segment was incubated with 1 mL of crystal violet dye in
deionized water (0.4% wt/vol) for 15 min, and then rinsed three
times with deionized water. Each segment was then incubated
with 1 mL dimethylsulfoxide (DMSO) for 4 h to resolve the
crystal violet staining biofilms on the segment surface. The
biofilm formation was evaluated using the absorbance of each
DMSO sample (OD600).
In-vitro anti-encrustation performance of whole
coated catheters in bladder model
To test the ability of coated and uncoated silicone catheters
to prevent encrustation and blockage, an in-vitro bladder
model (Figure 1b), similar to that described previously by
Stickler et al. [25], was applied. After sterilization of the
model, insertion of a sterile catheter and inflation of a catheter
balloon as described above, artificial urine (TSB concentration
1.0 g/L, prepared as described before [23]) was pumped intothe ‘bladder’ at a rate of 0.5 mL/min, and the urine drained via
the eye-hole of the catheter. Next, the urine supply was
switched off and P. mirabilis suspension in TSB was added to
the ‘bladder’ through the injection port, with initial bacterial
densities of w1106 or w1103 cells/mL. The model was
maintained for 1 h to allow P. mirabilis to establish itself in a
new environment before the supply of sterile urine was
switched on. The time taken for catheters to block was
recorded, and the pH and viable bacteria counts (plate
counting) of the urine drained through the catheter were
monitored throughout the experimental period. The catheter
was removed from the model after blockage. The eye-hole
section and the lumen section immediately below the eye-
hole were cut, washed, fixed and dehydrated as described
previously [26], and were then observed using an optical
microscope (Meiji Techno, Karnataka, Japan), and a scanning
electron microscope after being gold/platinum sputter-coated
(JSM-7400F, Jeol Ltd, Akishima, Japan).
Cytotoxicity assay
The extract test and direct contact test were performed to
evaluate the cytotoxicity of catheter segments with Ag-PTFE
nanocomposite coatings (RCV 72 mm2/mL) according to ISO
10993-5:2009. To prepare the extract, sterile segments of sil-
icone catheter and coated catheter were extracted with
Eagle’s Minimum Essential Medium (EMEM) with 10% fetal
bovine serum (FBS) at 37C for 24 h (ratio of coated surface
area/volume of extraction vehicle 1.5 cm2/mL). L929 fibro-
blast cells (NCTC clone 929, Catalogue No. 88102702, European
Collection of Authenticated Cell Cultures, London, UK) were
cultured with EMEM supplemented with 2 mM glutamine, 1%
non-essential amino acids and 10% FBS. The cell suspension was
prepared and adjusted to a density of 1105 cells/mL, and 100
mL of the suspension was seeded in each well of a 96-well plate.
After 24 h of incubation at 37C in a humidified atmosphere of
5% CO2, 100 mL of the extract medium or fresh culture medium
(blank) was used to replace the culture medium in each well.
The cells were then incubated for 24 h, and the extract medium







































































































































Figure 3. In-vitro evaluation of anti-encrustation performances of whole silicone (control, blue bar) and Ag-PTFE nanocomposite coated
(red bar) catheters using the bladder model shown in Figure 1b. (a) The time to blockage. *P>0.1. (b) Optical images of eye-hole sections
and scanning electron microscope images of lumen sections. Scale bar: 1 mm. (c) Density of viable cells in the drained urine. (d) pH of
drained urine. Blue lines, 103 cells/mL, control catheter; red lines, 106 cells/mL, control catheter; solid black lines, 103 cells/mL, coated
catheter; dashed black lines, 106 cells/mL, coated catheter.
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followed by the removal of MTT solution and the addition of 100
mL of isopropanol to dissolve the formazan crystals. Optical
absorbance of the samples was measured at 570 nm using a
microplate reader. The cell viability is the ratio of the mean
value of the measured optical density of the extracts of the
test sample and that of the blanks.
For the direct contact test, the catheter segment was cut
into small pieces, sterilized and placed at the bottom of the
well in a 12-well plate (sample pieces evenly covered approx-
imately one-third of the bottom area in each well). Blanks wereFigure 2. In-vitro evaluation of antibacterial performances of whole
using the bladder model shown in Figure 1a. (a) Time taken to develop
catheters. The distribution is the ratio of biofilms forming around th
catheter section inserted in the urethra. Blue bars, control catheter; re
catheter; red dashed lines, distribution for coated catheter.the wells without catheters. L929 cells were seeded at a den-
sity of 1104 cells/cm2. The culture medium was refreshed
every two days. The amount and the morphology of cells
growing on the well bottom were monitored using an optical
microscope (Leica DFC3000, Leica, Wetzlar, Germany). After
over 72 h of incubation, catheter samples were removed from
the well plate, rinsed with PBS and fixed with 2.5% gluta-
raldehyde overnight at 4C. The samples were dehydrated in a
series of ethanol solutions and critical point dried, before they
were sputter-coated with gold/platinum and observed using a
scanning electron microscope.silicone (control) and Ag-PTFE nanocomposite coated catheters
bacteriuria. (bed) Biofilm formation along the external surfaces of
e position of x (2 cm long) to the whole biofilms forming on the
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The above process was repeated twice independently. All
statistical analyses were performed using analysis of variance
testing within Excel (Microsoft Corp., Redmond, WA, USA).
Values were reported in the text as mean value  standard
deviation.
Results
In-vitro antibacterial performance of whole coated
catheters
Figure 2 summarizes the in-vitro results of coated catheters
in inhibiting the migration of E. coli along the external surface
of the catheter into the bladder. When the source of infection
around the urethral meatus was 106 cells/mL, it took less than
two days for E. coli to cause bacteriuria on control catheters,
which was consistent with the results presented by Darouiche
et al. [8]. In contrast, the time taken for coated catheters to
develop bacteriuria was more than twice as long, and the
biofilm formation on the external surface of coated catheters
was largely reduced (Figure 2aec). It is noteworthy that when
the source of infection was 102 cells/mL, the coated catheters
significantly extended the time to develop bacteriuria from an
average of six days (control) up to 41 days (P<0.005), but
formed a similar amount of biofilm on catheter surfaces as
control catheters (Figure 2a,d).
In-vitro anti-encrustation performance of whole
coated catheters
To test the anti-encrustation properties of Ag-PTFE nano-
composite coated catheters, coated and uncoated catheters
were challenged with a continuous flow of urine medium fol-
lowing bacterial contamination of the bladder. Figure 3a
reveals that control catheters blocked at 33.31.1 h and
36.21.1 h with an initial concentration of 106 and 103 cells/mL
in the bladder, respectively, whereas the coated catheters
resisted encrustation to 785.66 h (P<0.01) and 89.53.54 h
(P<0.005), respectively. It can be seen from Figure 3b that
when the eye-hole and the lumen of uncoated catheters were
heavily blocked, little sign of encrustation was visible on the
coated catheter.
When the bladder was initially infected by P. mirabilis 106
cells/mL, the quantitative changes of the viable cells in the
urine drained through the catheter were found to be the same
between the ‘bladder’ with uncoated and coated catheters. In
both cases, bacteria grew steadily from w1.0106 to
w2.6106 cells/mL. Likewise, the coated catheter did not
dramatically affect the variation of urinary pH; pH was sharply
increased from 6.0 to approximately 8.7 before slowly
increasing to approximately 9.0 (Figure 3c,d).
When the initial bacterial density was 103 cells/mL, the
coated catheter yielded a ‘lag phase’ for 0e8 h, in which no
obvious increase in the density of viable cells or in the pH of theFigure 4. Cytotoxicity results of silicone (control) and Ag-PTFE nanoco
segments. (b,c) Growth curves and optical images of cells on well pla
Scale bar: 100 mm. (d) Scanning electron microscope images of cells g
catheter; red line, coated catheter.drained urine was observed. In contrast, in uncoated silicone
catheters, bacteria grew immediately and rapidly raised the
urinary pH upon the addition of bacteria into the bladder
(Figure 3c,d). After the ‘lag phase’, the number of bacteria and
the pH gradually ascended.
Cytotoxicity assay
As extracts of coated catheters and coatings on surfaces
may contact with human cells, the extract test and the direct
contact test were conducted herein for future clinical trans-
lation. The MTT assays revealed that cell viability in extracts of
coated catheter segments was higher than 90%, comparable to
the control silicone samples (P>0.1) (Figure 4a). As shown in
Figure 4b,c, compared with cells growing in wells of blanks and
in those containing control samples, no dramatic difference in
cell growth caused by co-incubation with coated catheter
segments was observed, and Figure 4d shows that cells adhered
on both coated and uncoated surfaces spread well. Together,
the MTT assays, cell growth and cell morphology suggest that
the novel Ag-PTFE nanocomposite coating was not cytotoxic
but was highly biocompatible with cells.
Discussion
With the significant increase in antibiotic resistance, new
anti-infective coatings on urinary catheters have been devel-
oped as promising strategies to prevent CAUTIs (e.g. anti-
microbial peptide [27], multiblock copolymers [9] and silver
nanoparticle-polydopamine bilayers [23]). However, in these
studies, the antibacterial assays were only performed on
coated catheter segments which had been co-incubated with
bacterial suspensions for several hours; the antibacterial effi-
cacy of whole coated catheters, and whether coated catheters
could be applied for chronic catheterization, remain largely
unknown. This study used the in-vitro bladder model in
Figure 1a, and found that catheters coated with novel Ag-PTFE
nanocomposites exhibited excellent ability to impede migra-
tion of E. coli along the external catheter surface and to reduce
biofilm formation on the catheters.
The time taken for coatedanduncoated catheters todevelop
bacteriuria following contamination with E. coli depended on
the bacterial concentration around the urethral meatus. As
expected, a lower concentration resulted in a longer time to
develop bacteriuria. With the infection source lowered to 102
cells/mL, the time for coated catheters to inhibit bacteriuria
ascended to 6.9 times longer than that of bare silicone cathe-
ters. The non-bacteriuric female patients with a spinal cord
injury undergoing bladder catheterization, taken as an exam-
ple, had a mean log number of 0.65 E. coli around the urethral
meatus [28]. As such, it was speculated that coated catheters
could prevent bacteriuria formore than seven times longer than
uncoated catheters (i.e. for >41 days) in a patient.
It is interesting to note that the distribution pattern of
biofilm formation along the section inserted into the urethra
was independent of the bacterial concentration around themposite coated catheters. (a) MTT assays of extracts from catheter
tes under direct incubation with catheter segments, respectively.
rowing on catheter surfaces. Black line, blank; blue line, control
L. Wang et al. / Journal of Hospital Infection 103 (2019) 55e6362urethral meatus. The Gaussian-like distribution of biofilms
developing on control catheters implied that the middle sec-
tion of the urethra was the most susceptible to infections when
the silicone catheter was in situ. Unlike the uncoated catheter,
the majority of biofilms on the coated catheter developed near
the distal section of the urethra, which identified the role of
the coatings in inhibiting bacterial migration along the catheter
surface. Together with the effect of reducing biofilm for-
mation, catheters coated with Ag-PTFE nanocomposites may
reduce the risk of occurrence of symptomatic CAUTIs and
reduce the dose of antibiotics applied for necessary treatment
[19].
Besides bacteriuria, the blockage of the eye-hole and lumen
of the urinary catheter by encrustation is another critical issue
for patients undergoing catheterization, seriously compromis-
ing patients’ health and welfare [7]. The use of antimicrobial
coatings on indwelling catheters [23,29], which could elute
into the bladder and kill surrounding planktonic bacteria,
seems the simplest way to prevent encrustation. However, this
is limited due to difficulties in delivering effective concen-
trations of antimicrobial agents for prolonged periods [30].
Therefore, filling the retention balloon with solutions of
sodium nitrite [24] or triclosan [30,31] to control the urinary pH
and bacterial amount in the urine by diffusion has been widely
investigated. The toxicity of these solutions, however, needs to
be considered very carefully.
The anti-encrustation mechanism of the Ag-PTFE nano-
composite coatings was mainly due to its non-stick properties,
rather than its effect on surrounding P. mirabilis cells in the
urine medium (Figure 3); the presence of ammonia generated
by bacterial urease enzyme [7] leads to precipitation of cal-
cium and magnesium phosphates in the urine under alkaline
conditions, but few such precipitations attached to the eye-
hole and lumen of the coated catheters. The non-stick prop-
erties of Ag-PTFE nanocomposite coatings are due to its surface
energy, not just the contribution of PTFE [17,18,32]. It was
demonstrated that the Ag-PTFE coating with the electroless
plating technique gives an inherently uniform coating thickness
and mechanical integrity [17,18]. The PTFE content in the Ag-
PTFE coating was only approximately 5%, and the coating
thickness was approximately 1e2 mm, so the coating on the
balloon should not be an issue. However, the integrity of the
coating on the balloon during inflation/deflation has not been
determined to date, and will be investigated in future studies.
The urinary pH was elevated to approximately 7.5 after
P. mirabilis cells grew to >106 cells/mL in the bladder with
uncoated or coated catheters inserted; nevertheless, the time
to resist encrustation of control or coated catheters was
independent of the initial densities of bacteria infected in the
bladder, as no significant difference was found between the
blockage time for 106 cells/mL and 103 cells/mL (P>0.1 for
both control and coated catheters). This suggested that the
stage of bacterial growth from 103 to 106 cells/mL could con-
tribute to encrustation, even without the occurrence of visible
precipitations.
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